The Global Atopic Dermatitis treatment market is valued around USD 9.23 billion in 2018. It is predicted to grow at a CAGR of 13% to attain USD 17.01 billion by 2023. Atopic dermatitis, additionally known as eczema, is a situation in which skin turns into dry, itchy, and infected, which results in redness, swelling, scaling, and crusting. Atopic dermatitis is commonly observed in kids below one year. The precise reason of atopic dermatitis is undiscovered, but it is believed that it consists of genetics, environmental publicity, immune gadget dysfunction, and a problem with pores and skin permeability.
Introduction Hospital Pharmacies Retail Pharmacies Online Pharmacies Corticosteroids capture the most important market percentage and are predicted to retain their lead until the give up of 2022.
The leading industries dominating the market include Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
